MedTrace Logo

Compare Effects of a Soluble Fiber on Weight and Blood Cholesterol

NCT00682916 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2017-05-30

No results posted yet for this study

Summary

Obesity and type 2 diabetes have clearly been linked together and identified as epidemics in much of the developed world. Historically several different dietary fibers have been used as means of reducing body weight and the related development of type 2 diabetes. These studies have generated mixed, if not inconsistent, results suggesting that none of these fibers promise a solution to either of these two conditions. We are proposing to investigate the effects of including a new soluble fiber, a-cyclodextrin, FBCx® (to be called Y288 in this study), into the diet of adult overweight volunteers.

Conditions

Interventions

DIETARY_SUPPLEMENT

Y288

Subjects will take 2 tablets per fat containing meal, 3 times a day, within one hour of consuming the meal

DIETARY_SUPPLEMENT

Y288

Subjects will take 2 tablets per fat containing meal, 3 times a day, within one hour of consuming the meal

Sponsors & Collaborators

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Sidika E Kasim-Karakas, MD · UC Davis

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00682916 on ClinicalTrials.gov